Salmeterol to Formoterol Dose Equivalency
Salmeterol 50 mcg twice daily is approximately equivalent to formoterol 12 mcg twice daily for long-acting bronchodilation, though the provided evidence does not contain direct comparative dosing information between these two LABAs.
Standard Dosing for Each Agent
Based on FDA-approved dosing and clinical practice:
- Salmeterol: 50 mcg twice daily (standard dose for both asthma and COPD) 11
- Formoterol: 12 mcg twice daily (standard maintenance dose)
Clinical Context
The GOLD 2017 guidelines 2 recommend long-acting bronchodilators as foundational therapy for COPD but do not specify preferential use of one LABA over another, stating "there is no evidence to recommend one class of long-acting bronchodilators over another for symptom relief; the choice should depend on individual patient response."
Key Practical Considerations:
Onset of action differs significantly:
- Formoterol has a rapid onset (within 5 minutes), making it suitable for both maintenance and symptom relief
- Salmeterol has a slower onset (15-30 minutes), making it purely a maintenance medication
Duration and dosing frequency:
- Both are dosed twice daily for maintenance therapy
- Both provide approximately 12 hours of bronchodilation
Clinical Equivalency in Practice
When switching between these agents in real-world practice:
- Salmeterol 50 mcg BID ≈ Formoterol 12 mcg BID (standard maintenance doses)
- No dose adjustment is typically needed when switching at standard doses
- Monitor patient response after switching, as individual responses may vary
Important Caveats:
- Neither LABA should be used as monotherapy in asthma due to increased mortality risk 11
- Both are typically combined with inhaled corticosteroids in asthma
- In COPD, LABAs can be combined with LAMAs or ICS based on exacerbation history and symptom burden 2
- The evidence provided does not include direct head-to-head trials comparing salmeterol to formoterol at various dose ratios